DoD Bone Marrow Failure, Idea Development Award
ID: 354816Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354816
Timeline
    Description

    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is inviting proposals for the fiscal year 2024 (FY24) Bone Marrow Failure Research Program (BMFRP) Idea Development Award. This grant aims to support innovative research that advances the understanding and treatment of bone marrow failure (BMF) diseases, encouraging high-risk, high-reward projects that are based on scientifically sound evidence. With an estimated total program funding of $4.24 million, the program anticipates funding approximately five successful applications, with a pre-application deadline of July 17, 2024, and full applications due by October 9, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for assistance.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524BMFRPIDA_GG.pdf
    The Department of Defense's Bone Marrow Failure Research Program (BMFRP) is inviting proposals under its fiscal year 2024 (FY24) Idea Development Award. The program aims to advance research on bone marrow failure (BMF) diseases, focusing on understanding their causes, progression, and developing effective treatments or cures. An estimated $7.5 million is allocated for this funding opportunity, with the expectation that about five successful applications will be funded. Key timelines include a pre-application deadline of July 17, 2024, with invitations to submit full applications expected in August 2024 and final submissions due by October 9, 2024. Eligible applicants include established and early-career investigators associated with extramural and intramural organizations. Research proposals must address one or more specific focus areas related to BMF diseases, such as congenital or acquired conditions. The application process involves two steps: pre-application submission via eBRAP and full application through Grants.gov. Proposed projects must follow rigorous scientific protocols, demonstrate innovation, and describe potential impacts on BMF research and patient care. The BMFRP encourages high-risk, high-reward research while ensuring rigorous peer review and programmatic evaluation to determine funding based on scientific merit and relevance to the program's objectives.
    Similar Opportunities
    DoD Bone Marrow Failure, Investigator-Initiated Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Bone Marrow Failure Research Program (BMFRP) Investigator-Initiated Research Award, aimed at advancing research on bone marrow failure (BMF) diseases. This grant opportunity includes two funding levels: Funding Level 1 (FL1) focuses on developing mature ideas and translating discoveries into clinical applications, while Funding Level 2 (FL2) supports efforts to facilitate Investigational New Drug (IND) applications for promising therapeutic candidates. With a total estimated funding of $2.44 million available for two awards, the program encourages innovative and collaborative research proposals that address critical questions in BMF disease management. Interested applicants must submit a pre-application by July 17, 2024, with the full application due by October 9, 2024; for assistance, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 Rare Cancers Idea Development Award to support innovative research aimed at advancing the understanding and treatment of rare cancers. This grant opportunity encourages proposals that focus on understanding molecular pathways, developing tumor-specific models, or identifying novel therapies, with an emphasis on research that can significantly impact patient outcomes. The total funding available for this program is approximately $17.5 million, with individual awards capped at $350,000 over a three-year period, and applications are due in two stages: a pre-application by June 17, 2024, and a full application by September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    CDMRP Neurofibromatosis Exploration-Hypothesis Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Neurofibromatosis Exploration-Hypothesis Development Award, aimed at funding innovative research related to neurofibromatosis (NF). This grant supports the exploration of high-risk, high-gain concepts to enhance understanding and treatment of NF1, NF2, and schwannomatosis, with an estimated total program funding of $1.12 million and the expectation to fund approximately seven projects. The application process is two-tiered, requiring pre-applications by September 12, 2024, and full applications by October 3, 2024, with a focus on innovation, research feasibility, and impact on NF research and patient care. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Reconstructive Transplant, Idea Discovery Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Reconstructive Transplant Idea Discovery Award, a federal grant aimed at supporting innovative and high-risk research in reconstructive transplant and immunotherapy. This grant seeks to generate robust data that can lead to new scientific investigations, particularly focusing on enhancing immunosuppression techniques and advancing tissue preservation strategies relevant to military personnel and veterans. With an estimated total program funding of $2.5 million, the award will provide up to $500,000 for each selected project over a two-year period, contingent upon the availability of federal funds and the merit of applications. Interested applicants must submit a pre-application by August 7, 2024, followed by a full application due by October 23, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Multiple Sclerosis, Exploration - Hypothesis Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is inviting applications for the FY24 Multiple Sclerosis Exploration - Hypothesis Development Award (MSRP EHDA), aimed at fostering innovative research in the field of multiple sclerosis (MS). This grant program supports high-risk, high-gain research concepts that challenge existing paradigms and lay the groundwork for future scientific investigations, with a focus on areas such as central nervous system repair and mechanisms contributing to MS etiology. The total estimated funding for this program is approximately $2 million, with an expected eight awards, and applications must follow a two-step submission process, including a pre-application due by June 10, 2024, and a full application due by October 7, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Cancer, Idea Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Idea Award, a federal grant aimed at supporting innovative and high-risk cancer research relevant to military personnel, Veterans, and their families. This grant encourages proposals that challenge existing paradigms and explore new perspectives in cancer research, specifically excluding incremental advancements or ongoing projects. With an estimated total program funding of $16 million and the expectation of awarding approximately 20 grants, each project can receive up to $400,000 over a two-year period. Interested applicants must submit a pre-application by June 21, 2024, with full applications due later for those invited to proceed, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Combat Readiness - Medical, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Combat Readiness - Medical Translational Research Award (CRRP TRA) to support high-impact translational research aimed at enhancing medical readiness for military personnel. This funding opportunity seeks proposals that address critical areas such as battlefield diagnostics, treatments for life-threatening injuries, and operational health threats, with an emphasis on projects that leverage existing resources and demonstrate clear relevance to military health. The total estimated funding for this initiative is approximately $3.3 million, with the expectation of awarding around three grants, and key deadlines include pre-applications due by September 4, 2024, and full proposals by December 5, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Military Burn, Patient-Centered Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Military Burn, Patient-Centered Research Award, aimed at funding clinical research that enhances burn care for military personnel. This grant seeks to bridge the gap between research and clinical practice by supporting studies that focus on the implementation of evidence-based interventions, comparative effectiveness research, and the analysis of clinical data related to burn injuries. With an estimated total program funding of $4.4 million, the initiative anticipates awarding approximately two grants, with applications due by September 9, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further inquiries.
    DoD Kidney Cancer, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Kidney Cancer Research Program's Idea Development Award, aimed at advancing innovative and high-impact kidney cancer research. This grant opportunity encourages projects that align with strategic goals such as enhancing understanding of kidney cancer biology, developing novel therapies, and addressing healthcare disparities, with a focus on benefiting active-duty military personnel, veterans, and the general public. The total estimated funding for this program is approximately $18.56 million, with around 13 awards anticipated, and key deadlines include a pre-application due by September 24, 2024, and a full application deadline of October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Orthopaedic, Applied Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army's USAMRAA is offering the FY24 Peer Reviewed Orthopaedic Applied Research Award, aimed at funding applied research to enhance care for military personnel suffering from combat-related orthopaedic injuries. The program seeks innovative solutions that can translate into clinical applications, focusing on areas such as limb stabilization and battlefield care strategies, while excluding pure basic research. With an estimated total funding of $3.75 million to support approximately five awards, each capped at $750,000 over a maximum three-year period, interested applicants must submit pre-applications by June 18, 2024, followed by full applications due by September 17, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.